Yong Peng
Direktor/Vorstandsmitglied bei Beijing Shenogen Pharma Group Ltd.
Aktive Positionen von Yong Peng
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Beijing Shenogen Pharma Group Ltd.
 Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | Direktor/Vorstandsmitglied | 01.10.2019 | - |
| Corporate Officer/Principal | 01.07.2018 | - |
Karriereverlauf von Yong Peng
Ausbildung von Yong Peng
| Peking University | Doctorate Degree |
Statistik
International
| China | 3 |
Operativ
| Doctorate Degree | 1 |
| Director/Board Member | 1 |
| Corporate Officer/Principal | 1 |
Sektoral
| Consumer Services | 2 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | Health Technology |
